Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFair Oaks Inc R Regulatory News (FA17)

Share Price Information for Fair Oaks Inc R (FA17)

Share Price is delayed by 15 minutes
Get Live Data
0.48    0.00 (0.00%)
Bid:
0.46
Ask:
0.50
Spread: 0.04 (8.696%)
Market Cap: $27.90m
FA17 Live PriceLast checked at - London Stock Exchange

Intraday Fair Oaks Inc R Share Chart

Total Voting Rights

2 Apr 2024 09:54

RNS Number : 9448I
Fair Oaks Income Limited
02 April 2024
 

2 April 2024

 

FAIR OAKS INCOME LIMITED (the "Company")

 

(Incorporated in Guernsey under The Companies (Guernsey) Law, 2008, as amended, with registered number 58123 and registered as a Registered Closed-ended Collective Investment Scheme with the Guernsey Financial Services Commission)

 

Confirmation of Voting Rights

 

The Directors of the Company wish to announce that the total number of voting rights in respect of the following class of shares is:

Share Class

Number of shares in issue

Aggregate shares in issue

2021 Shares* 

Realisation Shares

405,815,477

49,906,358

455,721,835

*includes 23,412,179 2021 Shares held in Treasury.

2021 Shares and Realisation Shares each carry one vote per share held (excluding Shares held in Treasury). Therefore, the total number of voting rights in the Company is 432,309,656 and may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

LEI: 2138008KETEC1WM5YP90

 

Enquiries:

 

Fair Oaks Income Limited

Email: contact@fairoaksincome.com

Web: www.fairoaksincome.com

 

Fair Oaks Capital Limited

Investor Relations

DDI: +44 (0) 20 3034 0400

Email: ir@fairoakscap.com

 

Sanne Fund Services (Guernsey) Limited

Email: fairoaksgrp@apexfs.group 

 

Numis Securities Limited

Nathan Brown / Matt Goss, Investment Broking

DDI: +44 (0) 20 7260 1426/1642

Email: n.brown@numis.com / m.goss@numis.com

 

Liberum Capital Limited

Chris Clarke, Investment Banking

DDI: +44 (0) 20 3100 2190

Email: chris.clarke@liberum.com

 

 

 

 

 

 

 

 

Fair Oaks Income Limited

 

Fair Oaks Income Limited is a registered closed-ended investment company incorporated in Guernsey. The Company was admitted to trading on the Specialist Fund Market of the London Stock Exchange (now the Specialist Fund Segment of the Main Market of the London Stock Exchange) on 12 June 2014.

 

The investment policy of the Company is to invest (either directly and/or indirectly through FOIF II LP and FOMC III LP) in US and European CLOs or other vehicles and structures which provide exposure to portfolios consisting primarily of US and European floating-rate senior secured loans and which may include non-recourse financing.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREAPLAESDLEEA
Date   Source Headline
2nd Feb 202610:46 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSReinvestment of Management Fees
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 202610:04 amRNSDirector/PDMR Shareholding
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSNet Asset Value(s)
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 202610:45 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSNet Asset Value(s)
19th Nov 20257:00 amRNSDividend Currency Election
14th Nov 20257:00 amRNSNet Asset Value(s)
6th Nov 20257:00 amRNSDividend Declaration
31st Oct 202511:32 amRNSResult of Class Meeting and EGM
16th Oct 20257:00 amRNSNet Asset Value(s)
13th Oct 20257:00 amRNSCircular Publication & Shareholder Meeting Notices
1st Oct 20253:48 pmRNSTotal Voting Rights
1st Oct 20257:00 amRNSIssue of Treasury Shares
30th Sep 20257:01 amRNSProposed Extension of Master Fund III
30th Sep 20257:00 amRNSInterim Financial Report
15th Sep 20257:00 amRNSNet Asset Value(s)
21st Aug 20257:00 amRNSDividend Currency Election
18th Aug 20257:00 amRNSNet Asset Value(s)
7th Aug 20257:00 amRNSDividend Declaration
1st Aug 20257:00 amRNSTotal Voting Rights
29th Jul 20252:30 pmRNSReplacement - Redemption Currency Election
29th Jul 20257:00 amRNSRedemption Currency Election
28th Jul 20257:00 amRNSVoting Rights and Capital
18th Jul 20257:00 amRNSIssue of Treasury Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.